<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03966547</url>
  </required_header>
  <id_info>
    <org_study_id>GSPB-2018-SUB</org_study_id>
    <nct_id>NCT03966547</nct_id>
  </id_info>
  <brief_title>Changes in Cerebral Blood Flow (CBF) in Prone and Sitting Position Before and After GSP-block and Before and After Epidural Blood-patch: A Substudy of NCT03652714</brief_title>
  <official_title>Changes in Cerebral Blood Flow (CBF) in Prone and Sitting Position Before and After GSP-block and Before and After Epidural Blood-patch: A Substudy of NCT03652714</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Bispebjerg and Frederiksberg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Bispebjerg and Frederiksberg</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this optional sub-study to GSPB-2018 (NCT03652714) is to evaluate the changes&#xD;
      in cerebral blood flow (CBF) under different conditions to understand if postdural puncture&#xD;
      headache is caused by changes in the cerebral blood flow and if treatment normalises that&#xD;
      change.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Main study concluded before enrollment&#xD;
  </why_stopped>
  <start_date type="Anticipated">May 2020</start_date>
  <completion_date type="Anticipated">October 2020</completion_date>
  <primary_completion_date type="Anticipated">August 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Cerebral Blood Flow velcity (CBF) in supine versus upright position compared to effect of treatment.</measure>
    <time_frame>&lt;1h before and 1 hour after each intervention</time_frame>
    <description>Change in mean, minimum and maximum Cerebral Blood Flow velcity in cm/sec (CBF) in supine versus upright position compared to effect of treatment.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comparison of paint rating (0-100 on a visual analogue scale, VAS) and Cerebral Blood Flow velocity (CBF) before and after each intervention.</measure>
    <time_frame>&lt;1h before and 1 hour after each intervention</time_frame>
    <description>Pain intensity measured with a pain rating (0-100mm on a visual analogue scale, VAS) in supine position and as worst experienced pain after the patient has been upright for 30 seconds or the worst experienced pain while attempting to stand if the rating has to be interrupted.&#xD;
Cerebral Blood Flow velocity (CBF) measured as mean blood flow in cm/sec.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Cerebral Blood Flow velocity (CBF) in supine position before and after interventions.</measure>
    <time_frame>&lt;1h before and 1 hour after each intervention</time_frame>
    <description>Changes in mean, minimum and maximum Cerebral Blood Flow velocity in cm/sec (CBF) before and after treatment.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Postdural Puncture Headache</condition>
  <condition>Sphenopalatine Ganglion Block</condition>
  <arm_group>
    <arm_group_label>Local anesthetic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Isotonic NaCl</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ganglion sphenopalatine block with local anesthetic administered on study GSPB-2018</intervention_name>
    <description>Block performed with bilaterally inserted q-tips with 1:1 mixture of lidocaine 40mg/ml and ropivacaine 5mg/mL as per GSPB-2018.</description>
    <arm_group_label>Local anesthetic</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ganglion sphenopalatine block with placebo administered on study GSPB-2018</intervention_name>
    <description>Block performed with bilaterally inserted q-tips with isotone NaCl as per GSPB-2018.</description>
    <arm_group_label>Isotonic NaCl</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Study Population:&#xD;
&#xD;
        Subjects who have consented to participate in GSPB-2018 will be approached for&#xD;
        participation in this sub-study. Subjects who have consented to participate in GSPB-2018&#xD;
        are not required to participate in this sub-study.&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt; 18 years&#xD;
&#xD;
          -  Patients with postdural puncture headache defined as moderate to severe postural&#xD;
             headache (VAS &gt;= 30mm) after lumbar puncture or accidental dural puncture during&#xD;
             epidural insertion with an onset within 3 days following the puncture.&#xD;
&#xD;
          -  Lack of headache remission within 1 day after dural puncture and after treatment with&#xD;
             fluids, caffeine and paracetamol&#xD;
&#xD;
          -  Patients who have given their written informed consent for participation in the study&#xD;
             and substudy after fully understanding the protocol content and limitations.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who cannot cooperate to the study&#xD;
&#xD;
          -  Patients who does not understand or speak Danish&#xD;
&#xD;
          -  Allergy to the drugs used in the study&#xD;
&#xD;
          -  Has taken opioids within 12 hours prior to intervention&#xD;
&#xD;
          -  No possible transcranial window on transcranial doppler. If not possible to find a&#xD;
             useable window to get measurement the patient will be excluded and replaced with&#xD;
             another patient.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Bispebjerg and Frederiksberg Hospital, University of Copenhagen</name>
      <address>
        <city>Copenhagen</city>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rigshospitalet, University of Copenhagen</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>May 14, 2019</study_first_submitted>
  <study_first_submitted_qc>May 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 29, 2019</study_first_posted>
  <last_update_submitted>November 18, 2020</last_update_submitted>
  <last_update_submitted_qc>November 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Bispebjerg and Frederiksberg</investigator_affiliation>
    <investigator_full_name>Mads Seit Jespersen</investigator_full_name>
    <investigator_title>Medical Doctor, Primary Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Post-Dural Puncture Headache</mesh_term>
    <mesh_term>Headache</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

